vs
阿特斯（CSIQ）与TENET HEALTHCARE CORP（THC）财务数据对比。点击上方公司名可切换其他公司
TENET HEALTHCARE CORP的季度营收约是阿特斯的1.2倍（$5.5B vs $4.5B），TENET HEALTHCARE CORP净利率更高（11.7% vs 1.3%，领先10.4%）
阿特斯是全球领先的可再生能源企业，总部位于加拿大安大略省基奇纳。核心业务涵盖光伏组件制造、电池储能解决方案供应，以及大型公用事业级太阳能电站与储能项目的开发，业务布局覆盖全球主要能源市场。
Tenet Healthcare Corporation是总部位于美国达拉斯的营利性跨国医疗服务企业，旗下拥有USPI等多个品牌、子公司、合资企业及合作主体，运营65家医院及超过450个医疗设施，还通过旗下Conifer Health Solutions为各类医疗系统及其他客户提供专业医疗支持服务
CSIQ vs THC — 直观对比
营收规模更大
THC
是对方的1.2倍
$4.5B
净利率更高
THC
高出10.4%
1.3%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $4.5B | $5.5B |
| 净利润 | $57.6M | $644.0M |
| 毛利率 | 17.5% | — |
| 营业利润率 | 2.2% | 15.4% |
| 净利率 | 1.3% | 11.7% |
| 营收同比 | — | 9.0% |
| 净利润同比 | — | 12.6% |
| 每股收益（稀释后） | — | $4.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CSIQTHC
| Q4 25 | — | $5.5B | ||
| Q3 25 | $4.5B | $5.3B | ||
| Q2 25 | $3.0B | $5.3B | ||
| Q1 25 | $1.3B | $5.2B | ||
| Q4 24 | — | $5.1B | ||
| Q3 24 | $5.9B | $5.1B | ||
| Q2 24 | $4.1B | $5.1B | ||
| Q1 24 | — | $5.4B |
净利润CSIQTHC
| Q4 25 | — | $644.0M | ||
| Q3 25 | $57.6M | $579.0M | ||
| Q2 25 | $63.6M | $522.0M | ||
| Q1 25 | $36.2M | $622.0M | ||
| Q4 24 | — | $572.0M | ||
| Q3 24 | $366.8M | $681.0M | ||
| Q2 24 | $304.4M | $477.0M | ||
| Q1 24 | — | $2.3B |
毛利率CSIQTHC
| Q4 25 | — | — | ||
| Q3 25 | 17.5% | — | ||
| Q2 25 | 18.0% | — | ||
| Q1 25 | 19.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 18.0% | — | ||
| Q2 24 | 18.7% | — | ||
| Q1 24 | — | — |
营业利润率CSIQTHC
| Q4 25 | — | 15.4% | ||
| Q3 25 | 2.2% | 16.8% | ||
| Q2 25 | 3.3% | 15.6% | ||
| Q1 25 | 3.7% | 18.1% | ||
| Q4 24 | — | 16.2% | ||
| Q3 24 | 7.7% | 21.3% | ||
| Q2 24 | 9.1% | 14.9% | ||
| Q1 24 | — | 61.2% |
净利率CSIQTHC
| Q4 25 | — | 11.7% | ||
| Q3 25 | 1.3% | 10.9% | ||
| Q2 25 | 2.1% | 9.9% | ||
| Q1 25 | 2.7% | 11.9% | ||
| Q4 24 | — | 11.3% | ||
| Q3 24 | 6.2% | 13.3% | ||
| Q2 24 | 7.5% | 9.3% | ||
| Q1 24 | — | 43.5% |
每股收益（稀释后）CSIQTHC
| Q4 25 | — | $4.22 | ||
| Q3 25 | — | $3.86 | ||
| Q2 25 | — | $3.14 | ||
| Q1 25 | — | $4.27 | ||
| Q4 24 | — | $3.79 | ||
| Q3 24 | — | $4.89 | ||
| Q2 24 | — | $2.64 | ||
| Q1 24 | — | $21.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.7B | $2.9B |
| 总债务越低越好 | — | $13.1B |
| 股东权益账面价值 | $3.9B | $4.2B |
| 总资产 | $13.5B | $29.7B |
| 负债/权益比越低杠杆越低 | — | 3.10× |
8季度趋势，按日历期对齐
现金及短期投资CSIQTHC
| Q4 25 | — | $2.9B | ||
| Q3 25 | $1.7B | $3.0B | ||
| Q2 25 | $1.7B | $2.6B | ||
| Q1 25 | $1.7B | $3.0B | ||
| Q4 24 | — | $3.0B | ||
| Q3 24 | $1.9B | $4.1B | ||
| Q2 24 | $1.9B | $2.9B | ||
| Q1 24 | — | $2.5B |
总债务CSIQTHC
| Q4 25 | — | $13.1B | ||
| Q3 25 | — | $13.1B | ||
| Q2 25 | — | $13.1B | ||
| Q1 25 | — | $13.1B | ||
| Q4 24 | — | $13.1B | ||
| Q3 24 | — | $12.8B | ||
| Q2 24 | — | $12.8B | ||
| Q1 24 | — | $12.8B |
股东权益CSIQTHC
| Q4 25 | — | $4.2B | ||
| Q3 25 | $3.9B | $4.0B | ||
| Q2 25 | $3.9B | $3.7B | ||
| Q1 25 | $3.9B | $4.2B | ||
| Q4 24 | — | $4.2B | ||
| Q3 24 | $3.7B | $3.8B | ||
| Q2 24 | $3.7B | $3.5B | ||
| Q1 24 | — | $3.5B |
总资产CSIQTHC
| Q4 25 | — | $29.7B | ||
| Q3 25 | $13.5B | $29.4B | ||
| Q2 25 | $13.5B | $28.7B | ||
| Q1 25 | $13.5B | $29.2B | ||
| Q4 24 | — | $28.9B | ||
| Q3 24 | $11.9B | $29.4B | ||
| Q2 24 | $11.9B | $29.3B | ||
| Q1 24 | — | $28.9B |
负债/权益比CSIQTHC
| Q4 25 | — | 3.10× | ||
| Q3 25 | — | 3.26× | ||
| Q2 25 | — | 3.49× | ||
| Q1 25 | — | 3.13× | ||
| Q4 24 | — | 3.14× | ||
| Q3 24 | — | 3.33× | ||
| Q2 24 | — | 3.67× | ||
| Q1 24 | — | 3.70× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-187.7M | $731.0M |
| 自由现金流经营现金流 - 资本支出 | — | $367.0M |
| 自由现金流率自由现金流/营收 | — | 6.6% |
| 资本支出强度资本支出/营收 | — | 6.6% |
| 现金转化率经营现金流/净利润 | -3.26× | 1.14× |
| 过去12个月自由现金流最近4个季度 | — | $2.5B |
8季度趋势，按日历期对齐
经营现金流CSIQTHC
| Q4 25 | — | $731.0M | ||
| Q3 25 | $-187.7M | $1.1B | ||
| Q2 25 | — | $936.0M | ||
| Q1 25 | — | $815.0M | ||
| Q4 24 | — | $-331.0M | ||
| Q3 24 | — | $1.0B | ||
| Q2 24 | — | $747.0M | ||
| Q1 24 | — | $586.0M |
自由现金流CSIQTHC
| Q4 25 | — | $367.0M | ||
| Q3 25 | — | $778.0M | ||
| Q2 25 | — | $743.0M | ||
| Q1 25 | — | $642.0M | ||
| Q4 24 | — | $-661.0M | ||
| Q3 24 | — | $829.0M | ||
| Q2 24 | — | $602.0M | ||
| Q1 24 | — | $346.0M |
自由现金流率CSIQTHC
| Q4 25 | — | 6.6% | ||
| Q3 25 | — | 14.7% | ||
| Q2 25 | — | 14.1% | ||
| Q1 25 | — | 12.3% | ||
| Q4 24 | — | -13.0% | ||
| Q3 24 | — | 16.2% | ||
| Q2 24 | — | 11.8% | ||
| Q1 24 | — | 6.4% |
资本支出强度CSIQTHC
| Q4 25 | — | 6.6% | ||
| Q3 25 | — | 5.3% | ||
| Q2 25 | — | 3.7% | ||
| Q1 25 | — | 3.3% | ||
| Q4 24 | — | 6.5% | ||
| Q3 24 | — | 4.2% | ||
| Q2 24 | — | 2.8% | ||
| Q1 24 | — | 4.5% |
现金转化率CSIQTHC
| Q4 25 | — | 1.14× | ||
| Q3 25 | -3.26× | 1.83× | ||
| Q2 25 | — | 1.79× | ||
| Q1 25 | — | 1.31× | ||
| Q4 24 | — | -0.58× | ||
| Q3 24 | — | 1.53× | ||
| Q2 24 | — | 1.57× | ||
| Q1 24 | — | 0.25× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CSIQ
暂无分部数据
THC
| Other | $2.9B | 52% |
| Health Care Patient Service | $1.4B | 25% |
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | $1.2B | 22% |
| Health Care Other Sources | $56.0M | 1% |
